UCB
A U.S. Epilepsy and Rare Disease Communications Lead at UCB leads the development of integrated communication strategies for epilepsy and rare disease portfolios, partnering across medical, commercial, and regulatory teams. The role focuses on delivering compliant, patient-centered storytelling to advance disease awareness and strengthen connections with patients, caregivers, and healthcare professionals.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
51% above the average for this role
Regional Rare Disease Lead Epilepsy - Lombardia & Emilia Romagna
City of Pierre, South Dakota
Regional Rare Disease Lead Epilepsy - Lombardia & Emilia Romagna
City of Winnipeg
MSL Rare Disease & Epilepsy Poland
City of Winnipeg
Medical Science Liaison Rare Disease & Epilepsy Greece
City of Winnipeg
MSL Rare Disease & Epilepsy Poland
City of Pierre, South Dakota
Head of Epilepsy & Rare Syndromes US
City of Winnipeg